for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Cardiex Ltd

CDX.AX

Latest Trade

--

Change

--(--)

Today's Range

--

 - 

--

52 Week Range

--

 - 

--

As of on the Australian Stock Exchange Ltd ∙ Minimum 15 minute delay

Pricing

Previous Close
--
Open
--
Volume
--
3M AVG Volume
21.53
Today's High
--
Today's Low
--
52 Week High
--
52 Week Low
--
Shares Out (MIL)
695.50
Market Cap (MIL)
19.47
Forward P/E
--
Dividend (Yield %)
--

Latest Developments

More

CardieX Says C2 Ventures Converted Interest And Increased Holding Above 20%

Cardiex Ltd Enters Into Agreement To Co-Develop Consumer Wearable Applications With Mobvoi Information Technology

Cardiex Posts FY Revenue From Ordinary Activities $3.9 Mln

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Cardiex Ltd

Cardiex Ltd, formerly AtCor Medical Holdings Ltd, is engaged in the designing, manufacturing and marketing of medical devices for use in cardiovascular management. The Company operates through three segments: Americas, which includes global pharmaceutical trials business; Europe, which includes Middle East and Africa, and Asia Pacific, which includes Asia and Australia/New Zealand. The Company's clinical trial services, include study protocol assistance, study-specific user manual, operator training and certification, study-specific training materials, automated data transfer for expert over-read, quality assurance, ongoing data management, technical support and sponsor-defined data transfers. The Company also offers SphygmoCor technology, which is used in clinical trials for a range of therapeutic areas, including hypertension, renal disease, heart failure, inflammatory processes, diabetes and chronic obstructive pulmonary disease (COPD).

Industry

Medical Equipment & Supplies

Contact Info

Unit 11 1059 - 1063 Victoria Road

http://atcormedical.com/

Executive Leadership

Niall Charles Edgar Cairns

Executive Chairman of the Board

Craig Cooper

Chief Executive Officer, Executive Director

Peter Manley

Chief Financial Officer, Company Secretary

Chris Dax

President of AtCor Medical

Rhonda Welch

Vice President of Global Marketing

Key Stats

Price To Earnings (TTM)
--
Price To Sales (TTM)
4.79
Price To Book (MRQ)
2.80
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
65.21
LT Debt To Equity (MRQ)
15.60
Return on Investment (TTM)
-46.91
Return on Equity (TTM)
-30.36

Latest News

Latest News

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up